 | • レポートコード：QYR2104Z6194 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、131ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、リウマチ性心臓病のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（心筋炎、心膜炎）、用途別市場規模（病院、診断センター、研究センター）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・リウマチ性心臓病の市場動向 ・企業の競争状況、市場シェア ・リウマチ性心臓病の種類別市場規模（心筋炎、心膜炎） ・リウマチ性心臓病の用途別市場規模（病院、診断センター、研究センター） ・リウマチ性心臓病の北米市場規模2016-2027（アメリカ、カナダ） ・リウマチ性心臓病のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・リウマチ性心臓病のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・リウマチ性心臓病の中南米市場規模2016-2027（メキシコ、ブラジル） ・リウマチ性心臓病の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abbott Laboratories、Bayer、BIOTRONIK、Boston Scientific、Bristol-Myers Squibb、C. R. Bard、Cardinal Health、Cook Medical、Roche、GE Healthcare、InterValve、Novartis、On-X Life Technologies、Osypka Medical、Otsuka、PerkinElmer、Pfizer、Reckitt Benckiser、Siemens Healthineers、Toray） ・結論 |
Market Analysis and Insights: Global Rheumatic Heart Disease Market
The global Rheumatic Heart Disease market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Rheumatic Heart Disease market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Rheumatic Heart Disease market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Rheumatic Heart Disease market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Rheumatic Heart Disease market.
Global Rheumatic Heart Disease Scope and Market Size
Rheumatic Heart Disease market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Rheumatic Heart Disease market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Myocarditis
Pericarditis
Segment by Application
Hospital
Diagnostic Centre
Research Centre
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Abbott Laboratories
Bayer
BIOTRONIK
Boston Scientific
Bristol-Myers Squibb
C. R. Bard
Cardinal Health
Cook Medical
Roche
Boston Scientific
Bristol-Myers Squibb
Novartis
On-X Life Technologies
Osypka Medical
Otsuka
PerkinElmer
Pfizer
Reckitt Benckiser
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Rheumatic Heart Disease Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Myocarditis
1.2.3 Pericarditis
1.3 Market by Application
1.3.1 Global Rheumatic Heart Disease Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Diagnostic Centre
1.3.4 Research Centre
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Rheumatic Heart Disease Market Perspective (2016-2027)
2.2 Rheumatic Heart Disease Growth Trends by Regions
2.2.1 Rheumatic Heart Disease Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Rheumatic Heart Disease Historic Market Share by Regions (2016-2021)
2.2.3 Rheumatic Heart Disease Forecasted Market Size by Regions (2022-2027)
2.3 Rheumatic Heart Disease Industry Dynamic
2.3.1 Rheumatic Heart Disease Market Trends
2.3.2 Rheumatic Heart Disease Market Drivers
2.3.3 Rheumatic Heart Disease Market Challenges
2.3.4 Rheumatic Heart Disease Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Rheumatic Heart Disease Players by Revenue
3.1.1 Global Top Rheumatic Heart Disease Players by Revenue (2016-2021)
3.1.2 Global Rheumatic Heart Disease Revenue Market Share by Players (2016-2021)
3.2 Global Rheumatic Heart Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Rheumatic Heart Disease Revenue
3.4 Global Rheumatic Heart Disease Market Concentration Ratio
3.4.1 Global Rheumatic Heart Disease Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Rheumatic Heart Disease Revenue in 2020
3.5 Rheumatic Heart Disease Key Players Head office and Area Served
3.6 Key Players Rheumatic Heart Disease Product Solution and Service
3.7 Date of Enter into Rheumatic Heart Disease Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Rheumatic Heart Disease Breakdown Data by Type
4.1 Global Rheumatic Heart Disease Historic Market Size by Type (2016-2021)
4.2 Global Rheumatic Heart Disease Forecasted Market Size by Type (2022-2027)
5 Rheumatic Heart Disease Breakdown Data by Application
5.1 Global Rheumatic Heart Disease Historic Market Size by Application (2016-2021)
5.2 Global Rheumatic Heart Disease Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Rheumatic Heart Disease Market Size (2016-2027)
6.2 North America Rheumatic Heart Disease Market Size by Type
6.2.1 North America Rheumatic Heart Disease Market Size by Type (2016-2021)
6.2.2 North America Rheumatic Heart Disease Market Size by Type (2022-2027)
6.2.3 North America Rheumatic Heart Disease Market Size by Type (2016-2027)
6.3 North America Rheumatic Heart Disease Market Size by Application
6.3.1 North America Rheumatic Heart Disease Market Size by Application (2016-2021)
6.3.2 North America Rheumatic Heart Disease Market Size by Application (2022-2027)
6.3.3 North America Rheumatic Heart Disease Market Size by Application (2016-2027)
6.4 North America Rheumatic Heart Disease Market Size by Country
6.4.1 North America Rheumatic Heart Disease Market Size by Country (2016-2021)
6.4.2 North America Rheumatic Heart Disease Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Rheumatic Heart Disease Market Size (2016-2027)
7.2 Europe Rheumatic Heart Disease Market Size by Type
7.2.1 Europe Rheumatic Heart Disease Market Size by Type (2016-2021)
7.2.2 Europe Rheumatic Heart Disease Market Size by Type (2022-2027)
7.2.3 Europe Rheumatic Heart Disease Market Size by Type (2016-2027)
7.3 Europe Rheumatic Heart Disease Market Size by Application
7.3.1 Europe Rheumatic Heart Disease Market Size by Application (2016-2021)
7.3.2 Europe Rheumatic Heart Disease Market Size by Application (2022-2027)
7.3.3 Europe Rheumatic Heart Disease Market Size by Application (2016-2027)
7.4 Europe Rheumatic Heart Disease Market Size by Country
7.4.1 Europe Rheumatic Heart Disease Market Size by Country (2016-2021)
7.4.2 Europe Rheumatic Heart Disease Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Rheumatic Heart Disease Market Size (2016-2027)
8.2 Asia-Pacific Rheumatic Heart Disease Market Size by Type
8.2.1 Asia-Pacific Rheumatic Heart Disease Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Rheumatic Heart Disease Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Rheumatic Heart Disease Market Size by Type (2016-2027)
8.3 Asia-Pacific Rheumatic Heart Disease Market Size by Application
8.3.1 Asia-Pacific Rheumatic Heart Disease Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Rheumatic Heart Disease Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Rheumatic Heart Disease Market Size by Application (2016-2027)
8.4 Asia-Pacific Rheumatic Heart Disease Market Size by Region
8.4.1 Asia-Pacific Rheumatic Heart Disease Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Rheumatic Heart Disease Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Rheumatic Heart Disease Market Size (2016-2027)
9.2 Latin America Rheumatic Heart Disease Market Size by Type
9.2.1 Latin America Rheumatic Heart Disease Market Size by Type (2016-2021)
9.2.2 Latin America Rheumatic Heart Disease Market Size by Type (2022-2027)
9.2.3 Latin America Rheumatic Heart Disease Market Size by Type (2016-2027)
9.3 Latin America Rheumatic Heart Disease Market Size by Application
9.3.1 Latin America Rheumatic Heart Disease Market Size by Application (2016-2021)
9.3.2 Latin America Rheumatic Heart Disease Market Size by Application (2022-2027)
9.3.3 Latin America Rheumatic Heart Disease Market Size by Application (2016-2027)
9.4 Latin America Rheumatic Heart Disease Market Size by Country
9.4.1 Latin America Rheumatic Heart Disease Market Size by Country (2016-2021)
9.4.2 Latin America Rheumatic Heart Disease Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Rheumatic Heart Disease Market Size (2016-2027)
10.2 Middle East & Africa Rheumatic Heart Disease Market Size by Type
10.2.1 Middle East & Africa Rheumatic Heart Disease Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Rheumatic Heart Disease Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Rheumatic Heart Disease Market Size by Type (2016-2027)
10.3 Middle East & Africa Rheumatic Heart Disease Market Size by Application
10.3.1 Middle East & Africa Rheumatic Heart Disease Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Rheumatic Heart Disease Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Rheumatic Heart Disease Market Size by Application (2016-2027)
10.4 Middle East & Africa Rheumatic Heart Disease Market Size by Country
10.4.1 Middle East & Africa Rheumatic Heart Disease Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Rheumatic Heart Disease Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Rheumatic Heart Disease Introduction
11.1.4 Abbott Laboratories Revenue in Rheumatic Heart Disease Business (2016-2021)
11.1.5 Abbott Laboratories Recent Development
11.2 Bayer
11.2.1 Bayer Company Details
11.2.2 Bayer Business Overview
11.2.3 Bayer Rheumatic Heart Disease Introduction
11.2.4 Bayer Revenue in Rheumatic Heart Disease Business (2016-2021)
11.2.5 Bayer Recent Development
11.3 BIOTRONIK
11.3.1 BIOTRONIK Company Details
11.3.2 BIOTRONIK Business Overview
11.3.3 BIOTRONIK Rheumatic Heart Disease Introduction
11.3.4 BIOTRONIK Revenue in Rheumatic Heart Disease Business (2016-2021)
11.3.5 BIOTRONIK Recent Development
11.4 Boston Scientific
11.4.1 Boston Scientific Company Details
11.4.2 Boston Scientific Business Overview
11.4.3 Boston Scientific Rheumatic Heart Disease Introduction
11.4.4 Boston Scientific Revenue in Rheumatic Heart Disease Business (2016-2021)
11.4.5 Boston Scientific Recent Development
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Details
11.5.2 Bristol-Myers Squibb Business Overview
11.5.3 Bristol-Myers Squibb Rheumatic Heart Disease Introduction
11.5.4 Bristol-Myers Squibb Revenue in Rheumatic Heart Disease Business (2016-2021)
11.5.5 Bristol-Myers Squibb Recent Development
11.6 C. R. Bard
11.6.1 C. R. Bard Company Details
11.6.2 C. R. Bard Business Overview
11.6.3 C. R. Bard Rheumatic Heart Disease Introduction
11.6.4 C. R. Bard Revenue in Rheumatic Heart Disease Business (2016-2021)
11.6.5 C. R. Bard Recent Development
11.7 Cardinal Health
11.7.1 Cardinal Health Company Details
11.7.2 Cardinal Health Business Overview
11.7.3 Cardinal Health Rheumatic Heart Disease Introduction
11.7.4 Cardinal Health Revenue in Rheumatic Heart Disease Business (2016-2021)
11.7.5 Cardinal Health Recent Development
11.8 Cook Medical
11.8.1 Cook Medical Company Details
11.8.2 Cook Medical Business Overview
11.8.3 Cook Medical Rheumatic Heart Disease Introduction
11.8.4 Cook Medical Revenue in Rheumatic Heart Disease Business (2016-2021)
11.8.5 Cook Medical Recent Development
11.9 Roche
11.9.1 Roche Company Details
11.9.2 Roche Business Overview
11.9.3 Roche Rheumatic Heart Disease Introduction
11.9.4 Roche Revenue in Rheumatic Heart Disease Business (2016-2021)
11.9.5 Roche Recent Development
11.10 GE Healthcare
11.10.1 GE Healthcare Company Details
11.10.2 GE Healthcare Business Overview
11.10.3 GE Healthcare Rheumatic Heart Disease Introduction
11.10.4 GE Healthcare Revenue in Rheumatic Heart Disease Business (2016-2021)
11.10.5 GE Healthcare Recent Development
11.11 InterValve
11.11.1 InterValve Company Details
11.11.2 InterValve Business Overview
11.11.3 InterValve Rheumatic Heart Disease Introduction
11.11.4 InterValve Revenue in Rheumatic Heart Disease Business (2016-2021)
11.11.5 InterValve Recent Development
11.12 Novartis
11.12.1 Novartis Company Details
11.12.2 Novartis Business Overview
11.12.3 Novartis Rheumatic Heart Disease Introduction
11.12.4 Novartis Revenue in Rheumatic Heart Disease Business (2016-2021)
11.12.5 Novartis Recent Development
11.13 On-X Life Technologies
11.13.1 On-X Life Technologies Company Details
11.13.2 On-X Life Technologies Business Overview
11.13.3 On-X Life Technologies Rheumatic Heart Disease Introduction
11.13.4 On-X Life Technologies Revenue in Rheumatic Heart Disease Business (2016-2021)
11.13.5 On-X Life Technologies Recent Development
11.14 Osypka Medical
11.14.1 Osypka Medical Company Details
11.14.2 Osypka Medical Business Overview
11.14.3 Osypka Medical Rheumatic Heart Disease Introduction
11.14.4 Osypka Medical Revenue in Rheumatic Heart Disease Business (2016-2021)
11.14.5 Osypka Medical Recent Development
11.15 Otsuka
11.15.1 Otsuka Company Details
11.15.2 Otsuka Business Overview
11.15.3 Otsuka Rheumatic Heart Disease Introduction
11.15.4 Otsuka Revenue in Rheumatic Heart Disease Business (2016-2021)
11.15.5 Otsuka Recent Development
11.16 PerkinElmer
11.16.1 PerkinElmer Company Details
11.16.2 PerkinElmer Business Overview
11.16.3 PerkinElmer Rheumatic Heart Disease Introduction
11.16.4 PerkinElmer Revenue in Rheumatic Heart Disease Business (2016-2021)
11.16.5 PerkinElmer Recent Development
11.17 Pfizer
11.17.1 Pfizer Company Details
11.17.2 Pfizer Business Overview
11.17.3 Pfizer Rheumatic Heart Disease Introduction
11.17.4 Pfizer Revenue in Rheumatic Heart Disease Business (2016-2021)
11.17.5 Pfizer Recent Development
11.18 Reckitt Benckiser
11.18.1 Reckitt Benckiser Company Details
11.18.2 Reckitt Benckiser Business Overview
11.18.3 Reckitt Benckiser Rheumatic Heart Disease Introduction
11.18.4 Reckitt Benckiser Revenue in Rheumatic Heart Disease Business (2016-2021)
11.18.5 Reckitt Benckiser Recent Development
11.18 Siemens Healthineers
.1 Siemens Healthineers Company Details
.2 Siemens Healthineers Business Overview
.3 Siemens Healthineers Rheumatic Heart Disease Introduction
.4 Siemens Healthineers Revenue in Rheumatic Heart Disease Business (2016-2021)
.5 Siemens Healthineers Recent Development
11.20 Toray
11.20.1 Toray Company Details
11.20.2 Toray Business Overview
11.20.3 Toray Rheumatic Heart Disease Introduction
11.20.4 Toray Revenue in Rheumatic Heart Disease Business (2016-2021)
11.20.5 Toray Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Rheumatic Heart Disease Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Myocarditis
Table 3. Key Players of Pericarditis
Table 4. Global Rheumatic Heart Disease Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Rheumatic Heart Disease Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Rheumatic Heart Disease Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Rheumatic Heart Disease Market Share by Regions (2016-2021)
Table 8. Global Rheumatic Heart Disease Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Rheumatic Heart Disease Market Share by Regions (2022-2027)
Table 10. Rheumatic Heart Disease Market Trends
Table 11. Rheumatic Heart Disease Market Drivers
Table 12. Rheumatic Heart Disease Market Challenges
Table 13. Rheumatic Heart Disease Market Restraints
Table 14. Global Rheumatic Heart Disease Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Rheumatic Heart Disease Market Share by Players (2016-2021)
Table 16. Global Top Rheumatic Heart Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rheumatic Heart Disease as of 2020)
Table 17. Ranking of Global Top Rheumatic Heart Disease Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Rheumatic Heart Disease Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Rheumatic Heart Disease Product Solution and Service
Table 21. Date of Enter into Rheumatic Heart Disease Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Rheumatic Heart Disease Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Rheumatic Heart Disease Revenue Market Share by Type (2016-2021)
Table 25. Global Rheumatic Heart Disease Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Rheumatic Heart Disease Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Rheumatic Heart Disease Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Rheumatic Heart Disease Revenue Market Share by Application (2016-2021)
Table 29. Global Rheumatic Heart Disease Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Rheumatic Heart Disease Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Rheumatic Heart Disease Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Rheumatic Heart Disease Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Rheumatic Heart Disease Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Rheumatic Heart Disease Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Rheumatic Heart Disease Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Rheumatic Heart Disease Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Rheumatic Heart Disease Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Rheumatic Heart Disease Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Rheumatic Heart Disease Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Rheumatic Heart Disease Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Rheumatic Heart Disease Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Rheumatic Heart Disease Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Rheumatic Heart Disease Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Rheumatic Heart Disease Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Rheumatic Heart Disease Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Rheumatic Heart Disease Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Rheumatic Heart Disease Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Rheumatic Heart Disease Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Rheumatic Heart Disease Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Rheumatic Heart Disease Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Rheumatic Heart Disease Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Rheumatic Heart Disease Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Rheumatic Heart Disease Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Rheumatic Heart Disease Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Rheumatic Heart Disease Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Rheumatic Heart Disease Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Rheumatic Heart Disease Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Rheumatic Heart Disease Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Rheumatic Heart Disease Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Rheumatic Heart Disease Market Size by Country (2022-2027) & (US$ Million)
Table 61. Abbott Laboratories Company Details
Table 62. Abbott Laboratories Business Overview
Table 63. Abbott Laboratories Rheumatic Heart Disease Product
Table 64. Abbott Laboratories Revenue in Rheumatic Heart Disease Business (2016-2021) & (US$ Million)
Table 65. Abbott Laboratories Recent Development
Table 66. Bayer Company Details
Table 67. Bayer Business Overview
Table 68. Bayer Rheumatic Heart Disease Product
Table 69. Bayer Revenue in Rheumatic Heart Disease Business (2016-2021) & (US$ Million)
Table 70. Bayer Recent Development
Table 71. BIOTRONIK Company Details
Table 72. BIOTRONIK Business Overview
Table 73. BIOTRONIK Rheumatic Heart Disease Product
Table 74. BIOTRONIK Revenue in Rheumatic Heart Disease Business (2016-2021) & (US$ Million)
Table 75. BIOTRONIK Recent Development
Table 76. Boston Scientific Company Details
Table 77. Boston Scientific Business Overview
Table 78. Boston Scientific Rheumatic Heart Disease Product
Table 79. Boston Scientific Revenue in Rheumatic Heart Disease Business (2016-2021) & (US$ Million)
Table 80. Boston Scientific Recent Development
Table 81. Bristol-Myers Squibb Company Details
Table 82. Bristol-Myers Squibb Business Overview
Table 83. Bristol-Myers Squibb Rheumatic Heart Disease Product
Table 84. Bristol-Myers Squibb Revenue in Rheumatic Heart Disease Business (2016-2021) & (US$ Million)
Table 85. Bristol-Myers Squibb Recent Development
Table 86. C. R. Bard Company Details
Table 87. C. R. Bard Business Overview
Table 88. C. R. Bard Rheumatic Heart Disease Product
Table 89. C. R. Bard Revenue in Rheumatic Heart Disease Business (2016-2021) & (US$ Million)
Table 90. C. R. Bard Recent Development
Table 91. Cardinal Health Company Details
Table 92. Cardinal Health Business Overview
Table 93. Cardinal Health Rheumatic Heart Disease Product
Table 94. Cardinal Health Revenue in Rheumatic Heart Disease Business (2016-2021) & (US$ Million)
Table 95. Cardinal Health Recent Development
Table 96. Cook Medical Company Details
Table 97. Cook Medical Business Overview
Table 98. Cook Medical Revenue in Rheumatic Heart Disease Business (2016-2021) & (US$ Million)
Table 99. Cook Medical Recent Development
Table 100. Roche Company Details
Table 101. Roche Business Overview
Table 102. Roche Rheumatic Heart Disease Product
Table 103. Roche Revenue in Rheumatic Heart Disease Business (2016-2021) & (US$ Million)
Table 104. Roche Recent Development
Table 105. GE Healthcare Company Details
Table 106. GE Healthcare Business Overview
Table 107. GE Healthcare Rheumatic Heart Disease Product
Table 108. GE Healthcare Revenue in Rheumatic Heart Disease Business (2016-2021) & (US$ Million)
Table 109. GE Healthcare Recent Development
Table 110. InterValve Company Details
Table 111. InterValve Business Overview
Table 112. InterValve Rheumatic Heart Disease Product
Table 113. InterValve Revenue in Rheumatic Heart Disease Business (2016-2021) & (US$ Million)
Table 114. InterValve Recent Development
Table 115. Novartis Company Details
Table 116. Novartis Business Overview
Table 117. Novartis Rheumatic Heart Disease Product
Table 118. Novartis Revenue in Rheumatic Heart Disease Business (2016-2021) & (US$ Million)
Table 119. Novartis Recent Development
Table 120. On-X Life Technologies Company Details
Table 121. On-X Life Technologies Business Overview
Table 122. On-X Life Technologies Rheumatic Heart Disease Product
Table 123. On-X Life Technologies Revenue in Rheumatic Heart Disease Business (2016-2021) & (US$ Million)
Table 124. On-X Life Technologies Recent Development
Table 125. Osypka Medical Company Details
Table 126. Osypka Medical Business Overview
Table 127. Osypka Medical Rheumatic Heart Disease Product
Table 128. Osypka Medical Revenue in Rheumatic Heart Disease Business (2016-2021) & (US$ Million)
Table 129. Osypka Medical Recent Development
Table 130. Otsuka Company Details
Table 131. Otsuka Business Overview
Table 132. Otsuka Rheumatic Heart Disease Product
Table 133. Otsuka Revenue in Rheumatic Heart Disease Business (2016-2021) & (US$ Million)
Table 134. Otsuka Recent Development
Table 135. PerkinElmer Company Details
Table 136. PerkinElmer Business Overview
Table 137. PerkinElmer Rheumatic Heart Disease Product
Table 138. PerkinElmer Revenue in Rheumatic Heart Disease Business (2016-2021) & (US$ Million)
Table 139. PerkinElmer Recent Development
Table 140. Pfizer Company Details
Table 141. Pfizer Business Overview
Table 142. Pfizer Rheumatic Heart Disease Product
Table 143. Pfizer Revenue in Rheumatic Heart Disease Business (2016-2021) & (US$ Million)
Table 144. Pfizer Recent Development
Table 145. Reckitt Benckiser Company Details
Table 146. Reckitt Benckiser Business Overview
Table 147. Reckitt Benckiser Rheumatic Heart Disease Product
Table 148. Reckitt Benckiser Revenue in Rheumatic Heart Disease Business (2016-2021) & (US$ Million)
Table 149. Reckitt Benckiser Recent Development
Table 150. Siemens Healthineers Company Details
Table 151. Siemens Healthineers Business Overview
Table 152. Siemens Healthineers Rheumatic Heart Disease Product
Table 153. Siemens Healthineers Revenue in Rheumatic Heart Disease Business (2016-2021) & (US$ Million)
Table 154. Siemens Healthineers Recent Development
Table 155. Toray Company Details
Table 156. Toray Business Overview
Table 157. Toray Rheumatic Heart Disease Product
Table 158. Toray Revenue in Rheumatic Heart Disease Business (2016-2021) & (US$ Million)
Table 159. Toray Recent Development
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Rheumatic Heart Disease Market Share by Type: 2020 VS 2027
Figure 2. Myocarditis Features
Figure 3. Pericarditis Features
Figure 4. Global Rheumatic Heart Disease Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Diagnostic Centre Case Studies
Figure 7. Research Centre Case Studies
Figure 8. Rheumatic Heart Disease Report Years Considered
Figure 9. Global Rheumatic Heart Disease Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Rheumatic Heart Disease Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Rheumatic Heart Disease Market Share by Regions: 2020 VS 2027
Figure 12. Global Rheumatic Heart Disease Market Share by Regions (2022-2027)
Figure 13. Global Rheumatic Heart Disease Market Share by Players in 2020
Figure 14. Global Top Rheumatic Heart Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rheumatic Heart Disease as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Rheumatic Heart Disease Revenue in 2020
Figure 16. Global Rheumatic Heart Disease Revenue Market Share by Type (2016-2021)
Figure 17. Global Rheumatic Heart Disease Revenue Market Share by Type (2022-2027)
Figure 18. North America Rheumatic Heart Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Rheumatic Heart Disease Market Share by Type (2016-2027)
Figure 20. North America Rheumatic Heart Disease Market Share by Application (2016-2027)
Figure 21. North America Rheumatic Heart Disease Market Share by Country (2016-2027)
Figure 22. United States Rheumatic Heart Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Rheumatic Heart Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Rheumatic Heart Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Rheumatic Heart Disease Market Share by Type (2016-2027)
Figure 26. Europe Rheumatic Heart Disease Market Share by Application (2016-2027)
Figure 27. Europe Rheumatic Heart Disease Market Share by Country (2016-2027)
Figure 28. Germany Rheumatic Heart Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Rheumatic Heart Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Rheumatic Heart Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Rheumatic Heart Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Rheumatic Heart Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Rheumatic Heart Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Rheumatic Heart Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Rheumatic Heart Disease Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Rheumatic Heart Disease Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Rheumatic Heart Disease Market Share by Region (2016-2027)
Figure 38. China Rheumatic Heart Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Rheumatic Heart Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Rheumatic Heart Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Rheumatic Heart Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Rheumatic Heart Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Rheumatic Heart Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Rheumatic Heart Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Rheumatic Heart Disease Market Share by Type (2016-2027)
Figure 46. Latin America Rheumatic Heart Disease Market Share by Application (2016-2027)
Figure 47. Latin America Rheumatic Heart Disease Market Share by Country (2016-2027)
Figure 48. Mexico Rheumatic Heart Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Rheumatic Heart Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Rheumatic Heart Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Rheumatic Heart Disease Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Rheumatic Heart Disease Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Rheumatic Heart Disease Market Share by Country (2016-2027)
Figure 54. Turkey Rheumatic Heart Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Rheumatic Heart Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Rheumatic Heart Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Abbott Laboratories Revenue Growth Rate in Rheumatic Heart Disease Business (2016-2021)
Figure 58. Bayer Revenue Growth Rate in Rheumatic Heart Disease Business (2016-2021)
Figure 59. BIOTRONIK Revenue Growth Rate in Rheumatic Heart Disease Business (2016-2021)
Figure 60. Boston Scientific Revenue Growth Rate in Rheumatic Heart Disease Business (2016-2021)
Figure 61. Bristol-Myers Squibb Revenue Growth Rate in Rheumatic Heart Disease Business (2016-2021)
Figure 62. C. R. Bard Revenue Growth Rate in Rheumatic Heart Disease Business (2016-2021)
Figure 63. Cardinal Health Revenue Growth Rate in Rheumatic Heart Disease Business (2016-2021)
Figure 64. Cook Medical Revenue Growth Rate in Rheumatic Heart Disease Business (2016-2021)
Figure 65. Roche Revenue Growth Rate in Rheumatic Heart Disease Business (2016-2021)
Figure 66. GE Healthcare Revenue Growth Rate in Rheumatic Heart Disease Business (2016-2021)
Figure 67. InterValve Revenue Growth Rate in Rheumatic Heart Disease Business (2016-2021)
Figure 68. Novartis Revenue Growth Rate in Rheumatic Heart Disease Business (2016-2021)
Figure 69. On-X Life Technologies Revenue Growth Rate in Rheumatic Heart Disease Business (2016-2021)
Figure 70. Osypka Medical Revenue Growth Rate in Rheumatic Heart Disease Business (2016-2021)
Figure 71. Otsuka Revenue Growth Rate in Rheumatic Heart Disease Business (2016-2021)
Figure 72. PerkinElmer Revenue Growth Rate in Rheumatic Heart Disease Business (2016-2021)
Figure 73. Pfizer Revenue Growth Rate in Rheumatic Heart Disease Business (2016-2021)
Figure 74. Reckitt Benckiser Revenue Growth Rate in Rheumatic Heart Disease Business (2016-2021)
Figure 75. Siemens Healthineers Revenue Growth Rate in Rheumatic Heart Disease Business (2016-2021)
Figure 76. Toray Revenue Growth Rate in Rheumatic Heart Disease Business (2016-2021)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed
世界の炎症性心臓病市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Inflammatory Heart Disease Market The global Inflammatory Heart Disease market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, …- 世界の先天性心疾患市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Congenital Heart Disease Market The global Congenital Heart Disease market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the …
- 世界のリウマチ熱治療市場規模・現状・予測（2021年-2027年） Rheumatic fever is an autoimmune inflammatory disease which can develop as a complication of inadequately treated strep throat. Strep throat is a condition caused by group a Streptococcus bacterium. Rheumatic fever is common in the age group of 5 to 15 years, but adults can also have the condition. …
- 世界の先天性心疾患市場規模・現状・予測（2021年-2027年） Congenital diseases are disorders in a newborn due to certain genetic factors (and sometimes in association with the environment) that often results in malformations or underdeveloped organs. Congenital Heart Diseases (CHD) results in malformed or undeveloped heart that presents in a newborn with br…
- 世界のアルツハイマー病診断市場規模・現状・予測（2021年-2027年） Alzheimer's disease (AD), also referred to simply asAlzheimer's, is a chronic neurodegenerative diseasethat usually starts slowly and worsens over time. It is the cause of 60–70% of cases of dementia. The most common early symptom is difficulty in remembering recent events (short-term memory loss). …